Cameron Anderson

Cameron Anderson is a postgraduate researcher completing an industry-linked DPhil in therapeutic antibody engineering under the Howarth group at the University of Oxford, focusing on computational bioinformatics and experimental protein engineering. Previously, they served as a Risk Management Analyst at American Express, where they integrated a third-party fintech into credit underwriting processes, and held various positions in biotech and education, including a role as Director of Partnerships for Nucleate. Currently, Cameron is also a Venture Fellow at ARTIS Ventures and a visiting researcher at the University of Cambridge, while demonstrating a strong interest in biotech, entrepreneurship, and the application of science to healthcare. Cameron holds a Master's degree in Biochemistry from the University of Oxford.